We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Acrivon Therapeutics Inc | NASDAQ:ACRV | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -1.07 | -11.26% | 8.43 | 625,324 | 21:02:12 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 8.00 | 9.55 | 10.12 | 7.80 | 8.45 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | -60.39M | -2.7209 | -3.13 | 188.87M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:04:03 | 56 | 8.47 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/11/2023 | 13:58 | DJN | Acrivon Therapeutics Gets FDA's Breakthrough Designation for Cancer Assay |
Acrivon Therapeutics (ACRV) Share Charts1 Year Acrivon Therapeutics Chart |
|
1 Month Acrivon Therapeutics Chart |
Intraday Acrivon Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
